UnitedHealthcare
Perjeta (pertuzumab)
Drugs for Cancer : Drugs for Cancer
  • Prior Authorization: Breast Cancer: HR+ (HER2+):
    Documented Diagnosis: Yes
    Duration: 12 Month(s)
    Reauthorization Required: Yes

  • Breast Cancer: HR+ (HER2+):
    Duration: 12 Month(s)
    Specialist Required: Yes
    Documented Diagnosis: Yes
    Medical Test Required: No
    Specialist Type(s): Oncologist
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)